Nilotinib restores long-term full-donor chimerism in Ph-positive acute lymphoblastic leukemia relapsed after allogeneic transplantation. (Q46127676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Nilotinib restores long-term full-donor chimerism in Ph-positive acute lymphoblastic leukemia relapsed after allogeneic transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

lymphoblastic leukemia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Anna Amelia Colombo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Paolo Bernasconi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Simona Soverini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

S Calatroni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

B Rocca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Boni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

L Bonvini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

E P Alessandrino

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

9 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

263-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19204710%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2009.6

21 January 2020

exact match

0 references

cites work

Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challenges

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

7 January 2021

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

7 January 2021

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

7 January 2021

Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

7 January 2021

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

7 January 2021

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

7 January 2021

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

7 January 2021

Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.6

7 January 2021